TD Asset Management’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-32,534
| Closed | -$233K | – | 1509 |
|
|
2022
Q1 | $233K | Sell |
32,534
-18,900
| -37% | -$135K | ﹤0.01% | 1415 |
|
|
2021
Q4 | $881K | Buy |
51,434
+10,800
| +27% | +$185K | ﹤0.01% | 1298 |
|
|
2021
Q3 | $935K | Hold |
40,634
| – | – | ﹤0.01% | 1266 |
|
|
2021
Q2 | $1.23M | Buy |
+40,634
| New | +$1.23M | ﹤0.01% | 1214 |
|